OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026

ConferenceNeutral

AI Analysis

Summary

OnKure Therapeutics will host a virtual KOL event on July 15, 2026 to discuss PI3Kα inhibitor medicines, focusing on selectivity and pan-mutant allosteric inhibition.

Importance:3/10

Sentiment:

0.00

virtual eventKOL discussionPI3Kα inhibitorconference

Related Companies

$OKUR

Read the original article

Published by yahoo_finance on July 2, 2026 12:00 PM

Read Original